Alzheimer's disease is not only about the accumulation of toxic proteins in the brain. A growing number of studies indicate ...

A research team has confirmed that brain amyloid-β (Aβ) deposition, a biomarker for Alzheimer's disease, is an essential predictor for post-stroke cognitive impairment (PSCI) development and cognitive ...

Cerebral amyloid angiopathy (CAA) denotes the deposition of amyloid-β peptides within the walls of leptomeningeal and cortical blood vessels. It frequently co-occurs with Alzheimer’s disease and other ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today shared advances across its growing neuroscience portfolio at the Alzheimer’s Association International ...

A common type of brain bleed in older adults, known as subdural hemorrhage, is associated with the presence of amyloid deposits in cerebral blood vessels, according to a study led by researchers at ...

FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.

Please provide your email address to receive an email when new articles are posted on . Cerebral amyloid angiopathy was associated with a higher risk for isolated nontraumatic subdural hemorrhage in ...

Lecanemab decision marks first time patients can begin treatment with home administration ...